MELANIE BRENNAN: Open Payments
NPI 1356914782 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,196 in 61 payments from 15 companies in 2025. Trend: 2023 $810 · 2024 $1,121 · 2025 $1,196
Food & beverage: $1,117Education: $79
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $244 |
| Novo Nordisk Inc | 13 | $213 |
| Astellas Pharma US Inc | 4 | $147 |
| ABBVIE INC. | 8 | $140 |
| Sumitomo Pharma America, Inc. | 7 | $120 |
| Lilly USA, LLC | 3 | $63 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Esperion Therapeutics, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $36 |
Products named: NURTEC ODT, GEMTESA, ELIQUIS, Wegovy, Ozempic, UBRELVY, Veozah, QULIPTA.
Industry payments across FL — which companies pay providers there.
